Welcome to our dedicated page for Credo Technology Group Holding SEC filings (Ticker: CRDO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Credo Technology Group Holding's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Credo Technology Group Holding's regulatory disclosures and financial reporting.
Credo Technology Group Holding Ltd director and CTO Cheng Chi Fung reported open-market sales of Credo ordinary shares on behalf of the Cheng Huang Family Trust. On May 1, 2026, the trust sold a total of 27,500 shares in a series of trades under a Rule 10b5-1 trading plan adopted on September 5, 2025, at weighted average prices that ranged across the reported transactions. Following these sales, the trust holds 6,024,870 ordinary shares indirectly, and Cheng Chi Fung also holds 108,786 ordinary shares directly.
Credo Technology Group Holding Ltd director and Chief Technology Officer Cheng Chi Fung reported open-market sales of 27,500 ordinary shares of CRDO indirectly held by the Cheng Huang Family Trust on April 27, 2026. The filing describes these as routine open-market transactions under a Rule 10b5-1 trading plan adopted by the trust on September 5, 2025.
Individual trades were executed at reported prices including 2,633 shares at $180.7813 per share and 8,322 shares at $179.9178 per share. After these sales, the trust holds 6,052,370 ordinary shares indirectly associated with Cheng, and Cheng also holds 108,786 ordinary shares directly.
Credo Technology Group Holding Ltd director and Chief Technology Officer Cheng Chi Fung, through the Cheng Huang Family Trust, reported open-market sales of 27,500 ordinary shares on April 22, 2026 under a pre-arranged Rule 10b5-1 trading plan.
The shares were sold in multiple trades at weighted average prices reflecting ranges from about $184.13 to $190.73 per share, as detailed in the footnotes. Following these transactions, the family trust held 6,079,870 ordinary shares indirectly, while Cheng Chi Fung also held 108,786 ordinary shares directly.
Credo Technology Group Holding Ltd reported that the Cheng Huang Family Trust, a trust associated with Chief Technology Officer Cheng Chi Fung, sold 27,500 Ordinary Shares of the company in open-market transactions on April 16, 2026.
The sales were executed in multiple trade blocks at reported weighted average prices, under a pre-arranged Rule 10b5-1 trading plan adopted by the trust on September 5, 2025. After these transactions, the trust continues to hold about 6,107,370 Ordinary Shares indirectly for the reporting person and family members.
Credo Technology Group Holding Ltd Chief Legal Officer and Secretary James Laufman reported an open-market sale of 10,000 Ordinary Shares at $164.41 per share. After this transaction, he directly holds 198,609 Ordinary Shares. This filing shows a single routine share sale by a senior officer.
Credo Technology Group Holding Ltd’s Chief Financial Officer Daniel W. Fleming reported selling a total of 7,580 Ordinary Shares in two open-market transactions on April 14, 2026. He sold 6,669 shares at a weighted average price of $152.5086 and 911 shares at a weighted average price of $153.5362. The filing states these sales were executed under a pre-arranged Rule 10b5-1 trading plan adopted on January 12, 2026, indicating they were scheduled in advance. After these transactions, Fleming directly holds 433,678 Ordinary Shares. The trades were completed in multiple executions within price ranges of $152.07 to $153.03 and $153.47 to $153.63, with the reported prices reflecting weighted averages.
Credo Technology Group Holding Ltd director and CEO William Joseph Brennan reported a charitable share transfer linked to his indirect holdings. A trust associated with him made a bona fide gift of 7,500 ordinary shares from The Brennan Family Trust to The Brennan Family Fund, a charitable remainder trust, with no sale proceeds.
The filing notes that Brennan does not share voting or investment power over the securities held by the trust and disclaims beneficial ownership except for any pecuniary interest. After the gift, the trust-related indirect position is reported as 1,775,002 ordinary shares, and Brennan also reports 222,311 ordinary shares held directly.
Reporting person submitted a Form 144 to sell 27,580 shares of Common Stock. The notice lists Goldman Sachs & Co. LLC as the broker and a filing/date reference of 04/14/2026 with NASD. The schedule itemizes securities tied to compensation: 20,000 shares from a 05/11/2016 cashless exercise/same-day sale, and two Restricted Stock Unit entries of 3,790 shares each dated 04/02/2026 and 04/05/2026.
Credo Technology Group Holding Ltd director and Chief Technology Officer Cheng Chi Fung reported that the Cheng Huang Family Trust, with which he is associated, sold a total of 27,500 ordinary shares of Credo in open-market transactions on April 10, 2026 at weighted average prices ranging from about $109 to $121 per share.
The filing states these sales were carried out under a pre-arranged Rule 10b5-1 trading plan adopted by the Cheng Huang Family Trust on September 5, 2025. After these sales, the trust held 6,134,870 ordinary shares, and Cheng Chi Fung also held 108,786 ordinary shares directly.